GlobeNews Wire

Saudi Emerge Emergency and Crisis Resilience Platform Named Among the Worlds Best Smart City Solutions in the 2025 Smart City Awards

A national innovation supporting future-ready cities and major global event readiness…through a strategic partnership for transforming national crisis response November…

8 months ago

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

Multicenter outcomes FISH&CHIPS study of nearly 8,000 patients confirms total plaque volume as a powerful independent predictor of long-term cardiovascular…

8 months ago

George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Associations Scientific Sessions 2025

London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs…

8 months ago

Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025

November 09, 2025 09:00 ET  | Source: Medera Inc. BOSTON, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a…

8 months ago

Clearwater Wellness Launches World-First Thermoelectric Ice Bath, with Tim Paine Joining as Founding Partner

Clearwater Wellness Co launched the SnowCap, the world’s first thermoelectric ice bath requiring no ice or plumbing. Backed by $700,000…

8 months ago

Louis Limited Sets New Standard for Trading Psychology With Dynamic Emotion Tracking Features

Louis Limited sets a new benchmark in trading psychology with a feature-rich platform that combines real-time emotion tracking, behavioral analytics,…

8 months ago

AI Meets Digital Assets: CreditBlockchain Launches Free Cloud Trial for XRP Investors Era

New York, NY, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Credit Blockchain, a global fintech company pioneering AI-driven digital finance, today…

8 months ago

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

November 08, 2025 17:13 ET  | Source: Intellia Therapeutics, Inc. Deep, stable and durable reductions in kallikrein observed Among 32 patients…

8 months ago

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical…

8 months ago

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

November 08, 2025 11:45 ET  | Source: Vor Biopharma Treatment with telitacicept for 39 weeks resulted in a rapid, clinically…

8 months ago